Giles Campion
BioMarin (Netherlands)(NL)
Publications by Year
Research Areas
Muscle Physiology and Disorders, Cardiomyopathy and Myosin Studies, Neurogenetic and Muscular Disorders Research, Muscle activation and electromyography studies, Exercise and Physiological Responses
Most-Cited Works
- → A randomized placebo-controlled phase 3 trial of an antisense oligonucleotide, drisapersen, in Duchenne muscular dystrophy(2017)126 cited
- → Long-Term Efficacy, Safety, and Pharmacokinetics of Drisapersen in Duchenne Muscular Dystrophy: Results from an Open-Label Extension Study(2016)88 cited
- → Categorizing natural history trajectories of ambulatory function measured by the 6-minute walk distance in patients with Duchenne muscular dystrophy(2016)69 cited
- → Placebo‐controlled Phase 2 Trial of Drisapersen for Duchenne Muscular Dystrophy(2018)35 cited
- → Comparison of ambulatory capacity and disease progression of Duchenne muscular dystrophy subjects enrolled in the drisapersen DMD114673 study with a matched natural history cohort of subjects on daily corticosteroids(2016)19 cited
- → Longitudinal quantitative muscle magnetic resonance imaging (qMRI) in five boys with Duchenne muscular dystrophy (DMD), on and off treatment with drisapersen(2015)2 cited
- → G.P.113(2014)2 cited
- → Identification of Serum Biomarkers for Duchenne Muscular Dystrophy (P2.239)(2015)1 cited
- → Magnetic Resonance Imaging Assessments of two doses of Drisapersen in the Treatment of Ambulant Boys with Duchenne Muscular Dystrophy (P7.059)(2015)
- → Longitudinal quantitative muscle MRI in 5 Duchenne boys on and off drisapersen treatment(2015)